摘要
目的:观察中药愈肝方联合熊去氧胆酸(UDCA)治疗原发性胆汁性肝硬化(PBC)的临床疗效。方法:回顾性分析2007年1月-2010年12月在我院住院且符合纳入标准的PBC患者共66人,根据治疗方案不同,分为愈肝方与UDCA治疗组及UDCA治疗组,比较两组的临床疗效。结果:治疗4周后,愈肝方与UDCA组的好转率优于UDCA组,且在总胆红素、碱性磷酸酶两项主要生化指标方面均较UDCA组有显著下降。结论:愈肝方联合UDCA治疗原发性胆汁性肝硬化,较单用UDCA能更有效。
Objective：To study the clinical efficacy of Yuganfang combined with ursodeoxycholic acid in treatment of primary biliary cirrhosis.Methods： Restrospective analysis of 66 in-patients in our hospital during January 2007 and December 2010 who meet the inclusion criteria.According the different treatment,patients were divided into two groups,Yuganfang with UDCA group and UDCA group,the efficacy of the two groups were compared.Results： The treatment of Yuganfang with UDCA could increase the improvement rates better than UDCA,further more,the bio-chemical index of TBil and ALP decrease more significantly.Conclusion： Treatment of PBC with Yuganfang and UDCA is more effective than single UDCA.
出处
《中西医结合肝病杂志》
CAS
2011年第4期207-208,共2页
Chinese Journal of Integrated Traditional and Western Medicine on Liver Diseases
关键词
原发性胆汁性肝硬化
熊去氧胆酸
中药
联合治疗
primary biliary cirrhosis
ursodeoxycholic acid
Chinese herbs
integrated therapy
